Paradyne Corporation ***Text Omitted and and Filed Separately AG Communication Systems Corporation Confidential Treatment Requested Under Joint Development and Distribution Agreement 17 C.F.R. Sections 200.80(b)(4), 200.83 and 230.406 This Joint...Joint Development and Distribution Agreement • July 15th, 1999 • Paradyne Networks Inc • Electronic components & accessories • New York
Paladin to be Distributed by Certis in EuropeJoint Development and Distribution Agreement • September 9th, 2021
Arkema and Certis have entered into an exclusive joint development and distribution agreement in Europe for Paladin, a new pre-plant fumigant for modern and sustainable soil pest control.
Alimak Group (Alimak), the vertical access solution company, has signed an agreement with US based capital goods manufacturer Manitowoc Company Inc. (Manitowoc) regarding joint development and production of specialised internal tower crane elevators.Joint Development and Distribution Agreement • June 23rd, 2015
The agreement covers co-development and distribution of tower crane elevators. Alimak will supply its standardised external operator elevators adapted to fit the Manitowoc range of cranes that will be offered in both Alimak´s and Manitowoc´s respective global sales and distribution networks. In addition, Alimak has signed an exclusive distribution agreement with Manitowoc regarding an internal tower crane elevator, attached within the crane´s mast, which will be exclusively sold and distributed by Manitowoc.
Joint Development and Distribution Agreement with Fuji Pharma ~ Collaboration of Capabilities for End-to-end Solutions ~Joint Development and Distribution Agreement • November 12th, 2020
M3, Inc. (Headquarters: Tokyo, Japan; CEO: Itaru Tanimura; URL: https://corporate.m3.com/; “M3,” below) and Fuji Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President & CEO: Takayuki Iwai; URL: https://www.fujipharma.jp/; “Fuji Pharma” below), has announced an agreement for joint development and distribution of a Estetrol/Drospirenone combination product (“the product,” below), to establish a digitally optimized distribution structure upon its approval for manufacturing and distribution.
SPORTS MEDICINE JOINT DEVELOPMENT AND DISTRIBUTION AGREEMENT by and between Musculoskeletal Transplant Foundation, Inc. and CONMED Corporation dated as of January 3, 2012Joint Development and Distribution Agreement • January 3rd, 2012 • Conmed Corp • Electromedical & electrotherapeutic apparatus • New York
This Joint Development and Distribution Agreement (this “Agreement”), dated as of January 3, 2012 (“Effective Date”), is made and entered into by and between CONMED Corporation, a New York corporation having its principal place of business at 525 French Road, Utica, New York 13502, including its affiliates (“CONMED”), and Musculoskeletal Transplant Foundation, Inc., a District of Columbia nonprofit corporation having its principal place of business at 125 May Street, Suite 300, Edison, New Jersey 08837 (“MTF”). Each of CONMED and MTF is from time to time referred to herein, individually, as a “Party” and collectively, as the “Parties.”
